Gene · 2318
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CED-5/CED-12 (DOCK/ELMO) can promote and inhibit F-actin formation via distinct motifs that target different GTPases. | bioRxiv | 2023 | 37873140 | PubTator, text mining | PubMed |
| Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions. | Genome Med | 2023 | 37872640 | PubTator, text mining | PubMed |
| The application of radiology for dilated cardiomyopathy diagnosis, treatment, and prognosis prediction: a bibliometric analysis. | Quant Imaging Med Surg | 2023 | 37869323 | PubTator, text mining | PubMed |
| Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. | Oncogene | 2023 | 37864030 | PubTator, text mining | PubMed |
| MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes. | Cell Death Dis | 2023 | 37852977 | PubTator, text mining | PubMed |
| Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC. | Int J Mol Sci | 2023 | 37833968 | PubTator, text mining | PubMed |
| The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death. | NPJ Genom Med | 2023 | 37821546 | PubTator, text mining | PubMed |
| PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. | Front Immunol | 2023 | 37818357 | PubTator, text mining | PubMed |
| DNA methylation-based diagnosis confirmation in a pediatric patient with low-grade glioma: a case report. | Front Pediatr | 2023 | 37818165 | PubTator, text mining | PubMed |
| Mitochondrial transfer in hematological malignancies. | Biomark Res | 2023 | 37798791 | PubTator, text mining | PubMed |
| Revealing parental mosaicism: the hidden answer to the recurrence of apparent de novo variants. | Hum Genomics | 2023 | 37798624 | PubTator, text mining | PubMed |
| Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients. | Front Cardiovasc Med | 2023 | 37795486 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures. | Mol Cancer | 2023 | 37789377 | PubTator, text mining | PubMed |
| Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. | J Biomed Sci | 2023 | 37784171 | PubTator, text mining | PubMed |
| Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells. | Clin Epigenetics | 2023 | 37784136 | PubTator, text mining | PubMed |
| CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer. | Cancer Biomark | 2023 | 37781794 | PubTator, text mining | PubMed |
| The phenotypic and genetic features of arrhythmogenic cardiomyopathy in the pediatric population. | Front Cardiovasc Med | 2023 | 37781308 | PubTator, text mining | PubMed |
| A Stop-gain Variant c.220C>T (p.(Gln74*)) in FLNB Segregates with Spondylocarpotarsal Synostosis Syndrome in a Consanguineous Family. | Yale J Biol Med | 2023 | 37781000 | PubTator, text mining | PubMed |
| Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. | Cell Commun Signal | 2023 | 37770930 | PubTator, text mining | PubMed |
| Genetic Contribution to End-Stage Cardiomyopathy Requiring Heart Transplantation. | Circ Genom Precis Med | 2023 | 37767697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2318/papers?page=16